Discontinuation report IDHIFA
| Report ID | 193910 |
| Drug Identification Number | 02485427 |
| Brand name | IDHIFA |
| Common or Proper name | Enasidenib |
| Company Name | CELGENE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ENASIDENIB |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1X30 |
| ATC code | L01XX |
| ATC description | |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-06-08 |
| Remaining supply date | 2023-06-08 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Product deletion |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2344 ALFRED-NOBEL BOULEVARD SAINT-LAURENT, QUEBEC CANADA H4S 0A4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-06-09 | English | Compare |
| v2 | 2023-06-08 | French | Compare |
| v1 | 2023-06-08 | English | Compare |
Showing 1 to 3 of 3